UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 23, 2003
CardioDynamics International Corporation
(Exact name of registrant as specified in its charter)
California 0-11868 95-3533362
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
6175 Nancy Ridge Drive, San Diego, California 92121
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (858) 535-0202
--------------
n/a
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Items 5. Other Events:
Exhibit filed with this report:
Exhibit 1.1 Registrant's press release dated September 23, 2003, publicly
announcing five clinical studies presented at 7th Annual Heart Failure Society
of America Meeting.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CARDIODYNAMICS
INTERNATIONAL CORPORATION
Date: September 23, 2003 By: /s/ Michael K. Perry
---------------------
Michael K. Perry
Chief Executive Officer